|
English
|
正體中文
|
简体中文
|
2815035
|
|
???header.visitor??? :
27364364
???header.onlineuser??? :
582
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"ogusu n"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 中山醫學大學 |
2021 |
Response to: 'Correspondence on 'Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial'' by Zhao and Huang
|
Wei, JCC; Kim, TH; Kishimoto, M; Ogusu, N; Jeong, H; Kobayashi, S |
| 中山醫學大學 |
2021 |
Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial
|
Wei, JCC; Kim, TH; Kishimoto, M; Ogusu, N; Jeong, H; Kobayashi, S |
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
